Showing results (181-190 of 206) with videos related to

Sort By:
Pageof 21
Heart Disease (Hagerstown, Md.)|April 27, 2002
Coronary heart disease in African AmericansL T Clark, K C Ferdinand, J M Flack, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|November 1, 2016
Screening and Treatment for Subclinical Hypertensive Heart Disease in Emergency Department Patients With Uncontrolled Blood Pressure: A Cost-effectiveness AnalysisMichael J Twiner, Alexander L Marinica, Kenneth Kuper, et al.
American Journal of Hypertension|August 25, 2022
Does Vitamin D Provide Added Benefit to Antihypertensive Therapy in Reducing Left Ventricular Hypertrophy Determined by Cardiac Magnetic Resonance?Phillip D Levy, Michael J Twiner, Aaron M Brody, et al.
Ethnicity & Disease|November 25, 2003
The Metabolic Syndrome in African Americans: a reviewW Dallas Hall, Luther T Clark, Nanette K Wenger, et al.
Lancet (London, England)|March 7, 2026
Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trialMichel Azizi, Jenifer M Brown, Jamie P Dwyer, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 24, 2025
Baxdrostat for uncontrolled and resistant hypertension: rationale and design of the Phase 3 clinical trials BaxHTN, BaxAsia, and Bax24John M Flack, Michel Azizi, Jenifer M Brown, et al.
Chemsuschem|August 29, 2012
The synthesis and the chemical and physical properties of non-aqueous silylamine solvents for carbon dioxide captureAmy L Rohan, Jackson R Switzer, Kyle M Flack, et al.
Disease Management : DM|February 10, 2006
The metabolic syndrome: recognition and managementW Dallas Hall, Laurence O Watkins, Jackson T Wright, et al.
Kidney Medicine|December 4, 2023
Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD TrialsJohn M Flack, Rajiv Agarwal, Stefan D Anker, et al.
Hypertension (Dallas, Tex. : 1979)|December 30, 2015
Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort StudyGeorge Thomas, Dawei Xie, Hsiang-Yu Chen, et al.
Pageof 21